Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Merit Medical acquires remaining stake in Solo Pace for about $45 million

By Public Technologies
  • Merit Medical acquired Solo Pace's remaining outstanding equity for approximately $45 million on October 13, 2026.
  • It previously owned approximately 18% through agreements totaling $5 million, covering shares, an acquisition option and exclusive distribution rights.
  • The acquisition expands its Cardiac Therapies platform with temporary pacing technology for transcatheter aortic valve replacement and other transcatheter heart valve procedures.
  • The transaction is expected to have an immaterial impact on previously forecast full-year 2026 revenue and earnings.
  • For 2027, the acquisition is projected to be slightly accretive to non-GAAP earnings but slightly dilutive to GAAP earnings, becoming accretive thereafter.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merit Medical Systems Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610291603PRIMZONEFULLFEED9854630) on October 29, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.